PAPER Modirrousta M, Price BH, Dickerson BC

Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Neurodegener Dis Manag. 2013 Apr 1;3(2):133-146. PubMed: 23997827

PAPER D'Adamio L, Castillo PE

Presenilin-ryanodine receptor connection.

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14825-6. PubMed: 23995445

PAPER de Jong LW, Forsberg LE, Vidal JS, Sigurdsson S, Zijdenbos AP, Garcia M, Eiriksdottir G, Gudnason V, van Buchem MA, Launer LJ

Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors.

Neurobiol Aging. 2014 Jan;35(1):72-8. PubMed: 23992618

Ubiquitin Research and Drug Discovery Conference, 2014

CONFERENCE 2014-02-20 00:00:00-2014-02-21 00:00:00 San Diego, CA, U.S.A. 20 &#x2013 21 February 2014 This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the ubiquitin

Alzheimer's Research UK Conference 2014

CONFERENCE 2014-03-25 00:00:00-2014-03-26 00:00:00 Oxford, United Kingdom 25 &#x2013 26 March 2014 Alzheimer's Research UK Conference 2014 is the UK's largest dementia research conference. The meeting takes place 25-26 March 2014 at the Said Business School, Oxford, UK. The conference covers

Sarah Banks

Cleveland Clinic
United States

Steve Haggerty on Molecular Mechanism for Age-Related Memory Loss: The Histone-Binding Protein RbAp48.

COMMENT This elegant study by Kandel and colleagues represents a tour-de-force effort to integrate functional genomic studies spanning human post-mortem brain gene expression analysis to mouse models to uncover an important molecule involved in chromatin-mediated

Steve Haggerty

United States

Ashley Bush on The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain.

COMMENT We are aware of this work. We take it very seriously, and have been re-examining APP in different experimental systems. We will be publishing our own findings in due course. At this stage we cannot exclude the possibility that the apparent ferroxidase act

PAPER Waudby CA, Camilloni C, Fitzpatrick AW, Cabrita LD, Dobson CM, Vendruscolo M, Christodoulou J

In-Cell NMR Characterization of the Secondary Structure Populations of a Disordered Conformation of α-Synuclein within E. coli Cells.

PLoS One. 2013;8(8):e72286. PubMed: 23991082

PAPER Hetz C, Chevet E, Harding HP

Targeting the unfolded protein response in disease.

Nat Rev Drug Discov. 2013 Sep;12(9):703-19. PubMed: 23989796

PAPER Uyan Ö, Ömür Ö, Ağım ZS, Özoğuz A, Li H, Parman Y, Deymeer F, Oflazer P, Koç F, Tan E, Özçelik H, Başak AN

Genome-Wide Copy Number Variation in Sporadic Amyotrophic Lateral Sclerosis in the Turkish Population: Deletion of EPHA3 Is a Possible Protective Factor.

PLoS One. 2013;8(8):e72381. PubMed: 23991104

PAPER

Alzheimer's disease less common in people with non-melanoma skin cancer.

N Engl J Med. 2006 Dec 21;355(25):2652-63. PubMed: 23987689

PAPER

Exposure to general anaesthetic increases the risk of dementia in older people.

Perfusion. 2013 Sep 3; PubMed: 23987764

PAPER Xiang S, Yuan L, Fan W, Wang Y, Thompson PM, Ye J,

Bi-level multi-source learning for heterogeneous block-wise missing data.

Neuroimage. 2013 Aug 27; PubMed: 23988272